DoW Arthritis Clinical Research Award
Defense Health Agency Contracting Activity - DHACA · Military Medical Research and Development (12.420)
Publicada 1 may 2026 · Quedan 14 días
En pocas palabras
Resumen aún no disponible en español; se muestra en inglés.
The US Defense Health Agency funds clinical research and trials on arthritis prevention, early diagnosis, and treatment through its Fiscal Year 2026 Arthritis Research Program, with awards supporting two levels of research complexity. Applications from any type of US organisation or individual are welcome, and the deadline is 22 October 2026.
Un resumen generado del texto del donante; la redacción original figura más abajo.
Resumen
Texto original del donante (inglés)
Summary: The fiscal year 2026 (FY26) Arthritis Research Program (ATRP) Clinical Research Award (CRA) supports clinical research that evaluates disease-specific factors and interventions. Research is intended to generate clinically useful evidence with potential to optimize patient outcomes and inform clinical care or policy. Research addressing any and all types of arthritis is encouraged.
Applications must address one of two FY26 ATRP CRA Focus Areas: Prevention and Early Diagnosis, or Treatment and Mitigation of Disease Progression/Burden.
Distinctive Features: The FY26 ATRP CRA offers funding for two research levels. It is the responsibility of the applicant to select the level that aligns with the scope of the proposed research.
• Research Level 1: Applications proposing clinical research or early-phase/pilot clinical trials, to include new or emerging research that is not ready for a full-scale randomized controlled clinical trial.
• Research Level 2: Applications proposing a full-scale clinical trial.
Applications should include a community collaborator (e.g., patient/care partner, community-based organization consultant) who will provide advice and consultation during study…
Extracto de la página del donante. El texto completo, los anexos y los formularios están en la convocatoria original.
Quién puede presentar una solicitud
- ONG / sociedad civil
- Institución académica o de investigación
- Empresa privada
- Organismo gubernamental
- Persona física
- Organización comunitaria
Elegibilidad y condiciones
Mostrar el texto de elegibilidad de la fuente · Texto original del donante (inglés)
Applicant types: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"